← All candidates
One insider buy in the last year — $7.50M in all.
7 filings on record.
IMTXImmatics N.V.
NasdaqCM · Healthcare · $1.32B
$8.64
+0.47% today
One insider buy in the last year — $7.50M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 1 buy
▸ hover a marker for the filing · drag to zoom
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.32B
Float
70.1M
46% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
31.5
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Perceptive Advisors LLC
Bought $7.50M on Aug 26 — 863,060 sh @ $8.69, held indirect, 7.7% of their stake.
1 of 1 position beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Wall St
$17.63 avg target
+104.1% vs today · 6 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
1 of 4 quarters beat
Q2 '26−$0.53 act−$0.06
Q1 '26−$0.51 act−$0.07
Q4 '25−$0.34 act+$0.14
Q3 '25−$0.49 act−$0.03
The file stays open
7 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice